Potential Molecular Mechanisms of Ginsenosides for Alleviating Cancer-Related Fatigue and Clinical Research Progress of Ginseng Preparations: A Review
Molecules · 30.10.2026 · 31 (21) · 3917
DOI: 10.3390/molecules31213917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 30.10.2026. Verfasst von Jiaying Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolomics Laboratory, Department of Pharmaceutical Analysis, College of Pharmacy, National TCM Key Laboratory of Serum Pharmacochemistry, National…. Hauptthemen laut MEDLINE: Ginsenosides, Fatigue, Panax, Neoplasms. Die Arbeit nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dong'e Ejiao Co., Ltd., Dong’e Ejiao Co., Ltd..
Abstract (Originalsprache)
Cancer-related fatigue (CRF) is a persistent, subjective symptom experienced by patients with cancer over the course of the disease and its treatment. It can substantially impair patients’ quality of life, and its pathophysiological mechanisms remain incompletely understood. Ginseng is a traditional Chinese medicinal herb used to tonify qi and alleviate debility associated with prolonged illness. Clinical studies suggest that ginseng preparations may alleviate CRF to some extent. However, substantial heterogeneity among existing studies means that robust and reproducible evidence supporting the efficacy of ginseng in alleviating CRF remains insufficient. Ginsenosides are the major bioactive constituents of ginseng. Studies have reported several pharmacological effects of ginsenosides relevant to CRF, including anti-inflammatory effects and modulation of neuroendocrine function and muscle energy metabolism. These findings suggest that ginsenosides may have the potential to alleviate CRF. This review focuses on three representative ginsenosides (Rg1, Rg3, and Rb1), explores their potential molecular mechanisms in CRF alleviation, and reviews clinical studies of ginseng preparations for CRF management. Based on gaps in the current evidence, this review identifies priorities for future research to inform further studies of ginseng-based interventions for CRF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolomics Laboratory, Department of Pharmaceutical Analysis, College of Pharmacy, National TCM Key Laboratory of Serum Pharmacochemistry, National Chinmedomics Research Center, State Key Laboratory of Integration and…
- Shandong Key Laboratory of Gelatine Medicines Research and Development, Dong'e Ejiao Co., Ltd., Ejiao Road 78, Dong'e, Liaocheng 252200, China.
ORCID-Profile: Fuxiang Huang, Ning Zhang
Förderung
- Dong'e Ejiao Co., Ltd.
- Dong’e Ejiao Co., Ltd.
Zitieren
APA
Guo, J., Feng, Q., Shen, K., Cheng, J., Zhu, Y., Luan, Y., Gao, J., Zhu, S., Huang, F., Zhang, N., Wang, Z., & Sun, H. (2026). Potential Molecular Mechanisms of Ginsenosides for Alleviating Cancer-Related Fatigue and Clinical Research Progress of Ginseng Preparations: A Review. Molecules, 31(21), 3917. https://doi.org/10.3390/molecules31213917
Vancouver
Guo J, Feng Q, Shen K, Cheng J, Zhu Y, Luan Y, et al. Potential Molecular Mechanisms of Ginsenosides for Alleviating Cancer-Related Fatigue and Clinical Research Progress of Ginseng Preparations: A Review. Molecules. 2026;31(21):3917. doi:10.3390/molecules31213917
BibTeX
@article{Guo2026,
author = {Guo, Jiaying and Feng, Qin and Shen, Kunshuang and Cheng, Jie and Zhu, Yuying and Luan, Yinling and Gao, Jingzhe and Zhu, Shengnan and Huang, Fuxiang and Zhang, Ning and Wang, Zhigang and Sun, Hui},
title = {Potential Molecular Mechanisms of Ginsenosides for Alleviating Cancer-Related Fatigue and Clinical Research Progress of Ginseng Preparations: A Review},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {3917},
doi = {10.3390/molecules31213917}
}
EUVIMED